ESSA Pharma (EPIX) Stock Chart & Stock Price History $1.88 +0.01 (+0.27%) As of 07/25/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESSA Pharma Stock Price Performance The ESSA Pharma (EPIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.79%, with a year-to-date return of 5.03%. In the past month, the stock has increased 8.67%, reflecting recent market activity. As of the latest close, ESSA Pharma traded at $1.88 with a market cap of $83.45 million and volume of 185,577 shares. Five years ago, the stock traded at $6.25, representing a 69.92% decrease over that period. At the time, it had a market cap of $134.11 million and a volume of 41,872 shares. Receive EPIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.08%1 Month Performance+8.67%3 Month Performance+6.21%Year-To-Date Performance+5.03%1 Year Performance-64.79%5 Year Performance-69.92% EPIX Stock Chart for Sunday, July, 27, 2025 EPIX Chart by TradingView ESSA Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$1.87$1.88+0.53%$1.88$1.87185,577 shs$83.45 million07/24/2025$1.87$1.87$1.88$1.87118,175 shs$83.01 million07/23/2025$1.86$1.87+0.54%$1.88$1.87202,039 shs$83.01 million07/22/2025$1.87$1.86-0.53%$1.88$1.86294,031 shs$82.56 million07/21/2025$1.88$1.87-0.53%$1.88$1.87263,290 shs$83.01 million07/18/2025$1.87$1.88+0.53%$1.88$1.86328,689 shs$83.45 million07/17/2025$1.86$1.87+0.54%$1.87$1.862.22 million shs$83.01 million07/16/2025$1.87$1.86-0.53%$1.87$1.86641,094 shs$82.56 million07/15/2025$1.86$1.87+0.54%$1.87$1.86833,043 shs$83.01 million07/14/2025$1.71$1.86+8.77%$1.88$1.853.43 million shs$82.57 million Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$1.75$1.71-2.29%$1.75$1.7172,074 shs$75.91 million07/10/2025$1.71$1.75+2.34%$1.75$1.7059,340 shs$77.68 million07/09/2025$1.71$1.71$1.72$1.6957,210 shs$75.91 million07/08/2025$1.70$1.71+0.59%$1.71$1.6830,887 shs$75.91 million07/07/2025$1.74$1.70-2.02%$1.75$1.7041,191 shs$75.46 million07/04/2025$1.74$1.74$1.74$1.6948,109 shs$77.02 million07/03/2025$1.70$1.74+2.06%$1.74$1.6948,109 shs$77.02 million07/02/2025$1.73$1.70-1.73%$1.74$1.6774,483 shs$75.46 million07/01/2025$1.70$1.73+1.76%$1.75$1.7059,775 shs$76.80 million06/30/2025$1.73$1.70-1.73%$1.75$1.7039,329 shs$75.46 million06/27/2025$1.74$1.73-0.57%$1.75$1.7139,981 shs$76.80 million06/26/2025$1.74$1.74$1.75$1.7243,887 shs$77.24 million Related Companies Altimmune Stock Price Chart Amarin Stock Price Chart Palvella Therapeutics Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Inventiva Stock Price Chart Aldeyra Therapeutics Stock Price Chart Neurogene Stock Price Chart Capricor Therapeutics Stock Price Chart Cartesian Therapeutics Stock Price Chart Olema Pharmaceuticals Stock Price Chart Receive EPIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPIX) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
